Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Vanda Pharmaceuticals Inc. (VNDA) Profit Margins

Over the twelve months to 2026-06-30, Vanda Pharmaceuticals Inc. (VNDA) had gross margin 93.7%, operating margin -86.1%, net margin -127.4%, free cash flow margin -66.3%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

VNDAVanda Pharmaceuticals Inc.Follow VNDA — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
242.5M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
28 Oct, in 4 days
LineFY2011
Dec 11		FY2012
Dec 12		FY2013
Dec 13		FY2014
Dec 14		FY2015
Dec 15		FY2016
Dec 16		FY2017
Dec 17		FY2018
Dec 18		FY2019
Dec 19		FY2020
Dec 20		FY2021
Dec 21		FY2022
Dec 22		FY2023
Dec 23		FY2024
Dec 24		FY2025
Dec 25		TTM
Jun 26		Trend
Gross margin—99.6%—96.8%78.7%83.1%89.2%89.4%89.2%90.6%90.5%90.5%92.3%94.3%94.0%93.7%
Operating margin-34.2%-89.2%-62.6%40.0%-36.6%-12.7%-10.2%11.3%10.0%11.0%15.7%2.5%-7.2%-20.5%-70.0%-86.1%
Net margin-31.3%-87.4%-62.1%40.2%-36.3%-12.3%-9.4%13.1%50.9%9.4%12.3%2.5%1.3%-9.5%-102.0%-127.4%
FCF margin-91.7%-143.4%-117.4%-164.1%9.0%-6.5%-2.2%15.3%19.8%20.1%23.7%12.3%6.4%-8.2%-51.1%-66.3%

USD millions · SEC XBRL

Vanda Pharmaceuticals Inc. — questions

What is Vanda Pharmaceuticals Inc.'s gross margin?
93.7% over the twelve months to 2026-06-30.
What is Vanda Pharmaceuticals Inc.'s operating margin?
-86.1% over the twelve months to 2026-06-30.
What is Vanda Pharmaceuticals Inc.'s net profit margin?
-127.4% over the twelve months to 2026-06-30.

Every figure on this page comes from Vanda Pharmaceuticals Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.